¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2022 ´ëÇѸ¶Ãë¾à¸®ÇÐȸ Çмú´ëȸ : 2022-04-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2022 ´ëÇѸ¶Ãë¾à¸®ÇÐȸ Çмú´ëȸ : 2022-04-16
±³À°ÀÏÀÚ : 2022-04-16
±³À°Àå¼Ò : ¾Æ³­Æ¼ÄÚºê ¶ó¸Þ¸£, ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2022 ´ëÇѸ¶Ãë¾à¸®ÇÐȸ Çмú´ëȸ 
ÁÖÃÖ±â°ü : ´ëÇѸ¶Ãë¾à¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѸ¶Ãë¾à¸®ÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-459-8269  
À̸ÞÀÏ : ksap1996@gmail.com      
±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú¾à¸®ÇÐ,      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ(ȸ¿ø): 10,000¿øÀü¹®ÀÇ(ºñȸ¿ø): 50,000¿ø¿ø·Îȸ¿ø(65¼¼ÀÌ»ó ȸ¿ø): ¹«·áÀü°øÀÇ, °£È£»ç(¹«°ü): 10,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ10:00~10:40 Dynamic disruption: a fundamental mechanism of anesthesia?  Patrick L. Purdon(Harvard Medical School USA) 
Åä·Ð 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ10:40~10:55 Q&A  Patrick L. Purdon(Harvard Medical School USA) 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ10:55~11:25 Usefulness of computer-assisted individualized hemodynamic management in high-risk surgery  Maxime Cannesson(UCLA USA) 
Åä·Ð 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ11:25~11:45 Q&A  Maxime Cannesson(UCLA USA) 
½Ä»ç 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ11:45~12:30 Lunch  () 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ12:30~12:55 Sharing the practical experience of using remimazolam in general anesthesia or sedation  ±è¼ºÇù(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ12:55~13:20 Evidence of use of intravenous non-opioid analgesics (e.g., acetaminophen) for effective postoperative pain control  ·ùÅÂÇÏ(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ13:20~13:45 Expected advantage of istering antibiotics using target-concentration controlled infusion: vancomycin, cefazolin, and cefoxitin  ÃÖº´¹®(¿ï»êÀÇ´ë) 
Åä·Ð 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ13:45~14:00 Q&A  () 
È޽Ġ04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ14:00~14:15 Break  () 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ14:15~14:40 The usefulness of metaverse utilization in the field of anesthesia  °íÀçö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ14:40~15:05 Optimal fraction of inspired oxygen for patients undergoing general anesthesia  Àåöȣ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ15:05~15:30 Intraoperative fluid therapy in major surgery: which, when, how, and how much?  ±èÁøÅÂ(¼­¿ïÀÇ´ë) 
Åä·Ð 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ15:30~15:45 Q&A  () 
È޽Ġ04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ15:45~15:55 Break  () 
±³À°½Ã°£ 04-16 ¶ó¸Þ¸£,¿Â¶óÀΠ15:55~16:50 ÀÚÀ¯¿¬Á¦ ¹ßÇ¥  Çѵ¿¿ì(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2022 ´ëÇѸ¶Ãë¾à¸®ÇÐȸ Çмú´ëȸ : 2022-04-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) °­³²¼¼ºê¶õ½º ½ÅÀå³»°ú ¿¬¼ö°­Á : 2022-04-17
´ÙÀ½±Û (¿Â¶óÀÎ) 2022³âµµ Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÀΰÝÀå¾Ö Á¤½ÅÄ¡·á ¿öÅ©¼¥ 3 : 2022-04-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 5 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 9 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 11 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 9 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 8 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 12 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 10 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 10 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 7 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 3 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 5 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 9 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 4 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 6 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 6 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷